Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forn

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Dermatology (Basel, Switzerland)|January 1, 1995
Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study GroupA Alomar, S Videla, J Delgadillo, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1991
Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral doseJ Ramis, R Mis, J Forn, et al.
Arzneimittel-Forschung|June 1, 1992
Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazoleL Conte, J Ramis, R Mis, et al.
Mycoses|November 1, 1994
Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a randomized, multicentre, double-blind, comparative clinical trial with 1% clotrimazole cream. Flutrimazole Study GroupO Binet, J Soto-Melo, J Delgadillo, et al.
Journal of Medicinal Chemistry|November 1, 1991
Design of potent linear PAF antagonistsJ Bartrolí, E Carceller, M Merlos, et al.
British Journal of Pharmacology|July 1, 1996
Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shockM Giral, D Balsa, R Ferrando, et al.
Journal of Medicinal Chemistry|January 19, 1996
Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonistsE Carceller, M Merlos, M Giral, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 1996
Characterization of [3H]apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard methodD Balsa, M Merlos, M Giral, et al.
Nature: New Biology|April 14, 1971
Effect of noradrenaline and prostaglandin E1 on adenosine 3',5'-monophosphate formation in isolated pericardial fat cells of manJ Moskowitz, J P Harwood, J Forn, et al.
Drugs Under Experimental and Clinical Research|January 1, 1997
Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in ratsD Balsa, M Merlos, M Giral, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Dermatology (Basel, Switzerland)|January 1, 1995
Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study GroupA Alomar, S Videla, J Delgadillo, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1991
Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral doseJ Ramis, R Mis, J Forn, et al.
Arzneimittel-Forschung|June 1, 1992
Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazoleL Conte, J Ramis, R Mis, et al.
Mycoses|November 1, 1994
Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a randomized, multicentre, double-blind, comparative clinical trial with 1% clotrimazole cream. Flutrimazole Study GroupO Binet, J Soto-Melo, J Delgadillo, et al.
Journal of Medicinal Chemistry|November 1, 1991
Design of potent linear PAF antagonistsJ Bartrolí, E Carceller, M Merlos, et al.
British Journal of Pharmacology|July 1, 1996
Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shockM Giral, D Balsa, R Ferrando, et al.
Journal of Medicinal Chemistry|January 19, 1996
Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonistsE Carceller, M Merlos, M Giral, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 1996
Characterization of [3H]apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard methodD Balsa, M Merlos, M Giral, et al.
Nature: New Biology|April 14, 1971
Effect of noradrenaline and prostaglandin E1 on adenosine 3',5'-monophosphate formation in isolated pericardial fat cells of manJ Moskowitz, J P Harwood, J Forn, et al.
Drugs Under Experimental and Clinical Research|January 1, 1997
Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in ratsD Balsa, M Merlos, M Giral, et al.
Pageof 10